REMEGEN
๐ญ๐ฐHong Kong, China
- Country
- ๐ญ๐ฐHong Kong, China
- Ownership
- Public
- Established
- 2008-07-04
- Employees
- 3.4K
- Market Cap
- -
- Website
- http://www.remegen.com
- Introduction
The company was co-founded in 2008 by Yantai Rongchang Pharmaceutical Co., Ltd., headed by Mr. Wang Weidong, and American scientist Dr. Fang Jianmin. The company is committed to discovering, developing, producing and commercializing first-of-its-kind, best-in-class biopharmaceuticals, and creating a number of new biological drugs with significant clinical va...
Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- RemeGen Co., Ltd.
- Target Recruit Count
- 57
- Registration Number
- NCT02881190
- Locations
- ๐จ๐ณ
Beijing Cancer Hospital, Beijing, Beijing, China
ยฉ Copyright 2024. All Rights Reserved by MedPath